Atossa Therapeutics Statistics
Total Valuation
ATOS has a market cap or net worth of $25.75 million. The enterprise value is -$347,411.
| Market Cap | 25.75M |
| Enterprise Value | -347,411 |
Important Dates
The last earnings date was Friday, August 7, 2026, before market open.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATOS has 9.98 million shares outstanding. The number of shares has increased by 1.95% in one year.
| Current Share Class | 9.98M |
| Shares Outstanding | 9.98M |
| Shares Change (YoY) | +1.95% |
| Shares Change (QoQ) | +3.32% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 16.35% |
| Float | 9.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.69
| Current Ratio | 5.69 |
| Quick Ratio | 4.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -89.23% and return on invested capital (ROIC) is -58.05%.
| Return on Equity (ROE) | -89.23% |
| Return on Assets (ROA) | -50.69% |
| Return on Invested Capital (ROIC) | -58.05% |
| Return on Capital Employed (ROCE) | -146.30% |
| Weighted Average Cost of Capital (WACC) | 11.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.36M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.41% in the last 52 weeks. The beta is 1.25, so ATOS's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | -77.41% |
| 50-Day Moving Average | 2.34 |
| 200-Day Moving Average | 5.83 |
| Relative Strength Index (RSI) | 51.91 |
| Average Volume (20 Days) | 58,434 |
Short Selling Information
The latest short interest is 795,457, so 7.97% of the outstanding shares have been sold short.
| Short Interest | 795,457 |
| Short Previous Month | 760,127 |
| Short % of Shares Out | 7.97% |
| Short % of Float | 8.00% |
| Short Ratio (days to cover) | 12.76 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -39.25M |
| Pretax Income | -37.71M |
| Net Income | -37.71M |
| EBITDA | -39.24M |
| EBIT | -39.25M |
| Earnings Per Share (EPS) | -$4.34 |
Balance Sheet
The company has $26.09 million in cash and no debt, with a net cash position of $26.09 million or $2.61 per share.
| Cash & Cash Equivalents | 26.09M |
| Total Debt | n/a |
| Net Cash | 26.09M |
| Net Cash Per Share | $2.61 |
| Equity (Book Value) | 26.83M |
| Book Value Per Share | 2.69 |
| Working Capital | 25.56M |
Cash Flow
In the last 12 months, operating cash flow was -$35.77 million and capital expenditures -$14,000, giving a free cash flow of -$35.78 million.
| Operating Cash Flow | -35.77M |
| Capital Expenditures | -14,000 |
| Depreciation & Amortization | 16,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -35.78M |
| FCF Per Share | -$3.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.95% |
| Shareholder Yield | -1.95% |
| Earnings Yield | -146.46% |
| FCF Yield | -138.98% |
Analyst Forecast
The average price target for ATOS is $18.67, which is 623.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.67 |
| Price Target Difference | 623.64% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 2, 2026. It was a reverse split with a ratio of 1:15.
| Last Split Date | Feb 2, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |